{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:59:47Z","timestamp":1790247587604,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/emm.2017.205","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T15:45:51Z","timestamp":1515167151000},"page":"e423-e423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":148,"title":["Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration"],"prefix":"10.1038","volume":"50","author":[{"given":"Li","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton J","family":"Finegold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy L","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,5]]},"reference":[{"key":"BFemm2017205_CR1","doi-asserted-by":"publisher","first-page":"a019240","DOI":"10.1101\/cshperspect.a019240","volume":"7","author":"AI Penzo-Mendez","year":"2015","unstructured":"Penzo-Mendez AI, Stanger BZ . Organ-size regulation in mammals. Cold Spring Harb Perspect Biol 2015; 7: a019240.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"BFemm2017205_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1242\/dev.045500","volume":"138","author":"G Halder","year":"2011","unstructured":"Halder G, Johnson RL . Hippo signaling: growth control and beyond. Development 2011; 138: 9\u201322.","journal-title":"Development"},{"key":"BFemm2017205_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","volume":"19","author":"D Pan","year":"2010","unstructured":"Pan D . The hippo signaling pathway in development and cancer. Dev Cell 2010; 19: 491\u2013505.","journal-title":"Dev Cell"},{"key":"BFemm2017205_CR4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","volume":"163","author":"FX Yu","year":"2015","unstructured":"Yu FX, Zhao B, Guan KL . Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 2015; 163: 811\u2013828.","journal-title":"Cell"},{"key":"BFemm2017205_CR5","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.cub.2007.10.039","volume":"17","author":"FD Camargo","year":"2007","unstructured":"Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 2007; 17: 2054\u20132060.","journal-title":"Curr Biol"},{"key":"BFemm2017205_CR6","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","volume":"130","author":"J Dong","year":"2007","unstructured":"Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007; 130: 1120\u20131133.","journal-title":"Cell"},{"key":"BFemm2017205_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2009.09.026","volume":"16","author":"D Zhou","year":"2009","unstructured":"Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 2009; 16: 425\u2013438.","journal-title":"Cancer Cell"},{"key":"BFemm2017205_CR8","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1073\/pnas.0911427107","volume":"107","author":"L Lu","year":"2010","unstructured":"Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu Q et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA 2010; 107: 1437\u20131442.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2017205_CR9","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1073\/pnas.0911409107","volume":"107","author":"H Song","year":"2010","unstructured":"Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA 2010; 107: 1431\u20131436.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2017205_CR10","doi-asserted-by":"publisher","first-page":"8248","DOI":"10.1073\/pnas.0912203107","volume":"107","author":"KP Lee","year":"2010","unstructured":"Lee KP, Lee JH, Kim TS, Kim TH, Park HD, Byun JS et al. The Hippo\u2013Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci USA 2010; 107: 8248\u20138253.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2017205_CR11","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1126\/science.1199010","volume":"332","author":"T Heallen","year":"2011","unstructured":"Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, Johnson RL et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 2011; 332: 458\u2013461.","journal-title":"Science"},{"key":"BFemm2017205_CR12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrm3416","volume":"13","author":"G Halder","year":"2012","unstructured":"Halder G, Dupont S, Piccolo S . Transduction of mechanical and cytoskeletal cues by YAP and TAZ. Nat Rev Mol Cell Biol 2012; 13: 591\u2013600.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFemm2017205_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Meng Z, Moroishi T, Guan KL . Mechanisms of Hippo pathway regulation. Genes Dev 2016; 30: 1\u201317.","journal-title":"Genes Dev"},{"key":"BFemm2017205_CR14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1242\/dev.126920","volume":"143","author":"J Wang","year":"2016","unstructured":"Wang J, Xiao Y, Hsu CW, Martinez-Traverso IM, Zhang M, Bai Y et al. Yap and Taz play a crucial role in neural crest-derived craniofacial development. Development 2016; 143: 504\u2013515.","journal-title":"Development"},{"key":"BFemm2017205_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V","volume":"26","author":"C Postic","year":"2000","unstructured":"Postic C, Magnuson MA . DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 2000; 26: 149\u2013150.","journal-title":"Genesis"},{"key":"BFemm2017205_CR16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/nprot.2008.80","volume":"3","author":"C Mitchell","year":"2008","unstructured":"Mitchell C, Willenbring H . A reproducible and well-tolerated method for 2\/3 partial hepatectomy in mice. Nat Protoc 2008; 3: 1167\u20131170.","journal-title":"Nat Protoc"},{"key":"BFemm2017205_CR17","doi-asserted-by":"publisher","first-page":"G196","DOI":"10.1152\/ajpgi.00077.2014","volume":"307","author":"JL Grijalva","year":"2014","unstructured":"Grijalva JL, Huizenga M, Mueller K, Rodriguez S, Brazzo J, Camargo F et al. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Am J Physiol Gastrointest Liver Physiol 2014; 307: G196\u2013G204.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFemm2017205_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.15252\/emmm.201506089","volume":"9","author":"G Loforese","year":"2017","unstructured":"Loforese G, Malinka T, Keogh A, Baier F, Simillion C, Montani M et al. Impaired liver regeneration in aged mice can be rescued by silencing Hippo core kinases MST1 and MST2. EMBO Mol Med 2017; 9: 46\u201360.","journal-title":"EMBO Mol Med"},{"key":"BFemm2017205_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.devcel.2010.06.015","volume":"19","author":"N Zhang","year":"2010","unstructured":"Zhang N, Bai H, David KK, Dong J, Zheng Y, Cai J et al. The Merlin\/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell 2010; 19: 27\u201338.","journal-title":"Dev Cell"},{"key":"BFemm2017205_CR20","doi-asserted-by":"publisher","first-page":"11961","DOI":"10.1038\/ncomms11961","volume":"7","author":"DH Lee","year":"2016","unstructured":"Lee DH, Park JO, Kim TS, Kim SK, Kim TH, Kim MC et al. LATS-YAP\/TAZ controls lineage specification by regulating TGFbeta signaling and Hnf4alpha expression during liver development. Nat Commun 2016; 7: 11961.","journal-title":"Nat Commun"},{"key":"BFemm2017205_CR21","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1002\/hep.28768","volume":"64","author":"J Yi","year":"2016","unstructured":"Yi J, Lu L, Yanger K, Wang W, Sohn BH, Stanger BZ et al. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ. Hepatology 2016; 64: 1757\u20131772.","journal-title":"Hepatology"},{"key":"BFemm2017205_CR22","doi-asserted-by":"publisher","first-page":"G493","DOI":"10.1152\/ajpgi.00056.2011","volume":"302","author":"S Septer","year":"2012","unstructured":"Septer S, Edwards G, Gunewardena S, Wolfe A, Li H, Daniel J et al. Yes-associated protein is involved in proliferation and differentiation during postnatal liver development. Am J Physiol Gastrointest Liver Physiol 2012; 302: G493\u2013G503.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFemm2017205_CR23","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/hep.25769","volume":"56","author":"H Bai","year":"2012","unstructured":"Bai H, Zhang N, Xu Y, Chen Q, Khan M, Potter JJ et al. Yes-associated protein regulates the hepatic response after bile duct ligation. Hepatology 2012; 56: 1097\u20131107.","journal-title":"Hepatology"},{"key":"BFemm2017205_CR24","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1101\/gad.1978810","volume":"24","author":"J Cai","year":"2010","unstructured":"Cai J, Zhang N, Zheng Y, de Wilde RF, Maitra A, Pan D . The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev 2010; 24: 2383\u20132388.","journal-title":"Genes Dev"},{"key":"BFemm2017205_CR25","doi-asserted-by":"publisher","first-page":"352ra108","DOI":"10.1126\/scitranslmed.aaf2304","volume":"8","author":"F Fan","year":"2016","unstructured":"Fan F, He Z, Kong LL, Chen Q, Yuan Q, Zhang S et al. Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration. Sci Transl Med 2016; 8: 352ra108.","journal-title":"Sci Transl Med"},{"key":"BFemm2017205_CR26","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.cell.2011.02.031","volume":"144","author":"K Schlegelmilch","year":"2011","unstructured":"Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D et al. Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 2011; 144: 782\u2013795.","journal-title":"Cell"},{"key":"BFemm2017205_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1126\/science.276.5309.60","volume":"276","author":"GK Michalopoulos","year":"1997","unstructured":"Michalopoulos GK, DeFrances MC . Liver regeneration. Science 1997; 276: 60\u201366.","journal-title":"Science"},{"key":"BFemm2017205_CR28","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jhep.2015.05.031","volume":"63","author":"MV Machado","year":"2015","unstructured":"Machado MV, Michelotti GA, Pereira TA, Xie G, Premont R, Cortez-Pinto H et al. Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease. J Hepatol 2015; 63: 962\u2013970.","journal-title":"J Hepatol"},{"key":"BFemm2017205_CR29","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","volume":"24","author":"X Wang","year":"2016","unstructured":"Wang X, Zheng Z, Caviglia JM, Corey KE, Herfel TM, Cai B et al. Hepatocyte TAZ\/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis. Cell Metab 2016; 24: 848\u2013862.","journal-title":"Cell Metab"},{"key":"BFemm2017205_CR30","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1101\/gad.192856.112","volume":"26","author":"Y Liu-Chittenden","year":"2012","unstructured":"Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev 2012; 26: 1300\u20131305.","journal-title":"Genes Dev"},{"key":"BFemm2017205_CR31","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.celrep.2015.02.027","volume":"10","author":"J Fitamant","year":"2015","unstructured":"Fitamant J, Kottakis F, Benhamouche S, Tian HS, Chuvin N, Parachoniak CA et al. YAP inhibition restores hepatocyte differentiation in advanced HCC, leading to tumor regression. Cell Rep 2015; 10: 1692\u20131707.","journal-title":"Cell Rep"},{"key":"BFemm2017205_CR32","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1158\/1078-0432.CCR-15-1447","volume":"22","author":"BH Sohn","year":"2016","unstructured":"Sohn BH, Shim JJ, Kim SB, Jang KY, Kim SM, Kim JH et al. Inactivation of Hippo pathway is significantly associated with poor prognosis in hepatocellular carcinoma. Clin Cancer Res 2016; 22: 1256\u20131264.","journal-title":"Clin Cancer Res"},{"key":"BFemm2017205_CR33","first-page":"69","volume":"2","author":"V Valero 3rd","year":"2015","unstructured":"Valero V 3rd, Pawlik TM, Anders RA . Emerging role of Hpo signaling and YAP in hepatocellular carcinoma. J Hepatocell Carcinoma 2015; 2: 69\u201378.","journal-title":"J Hepatocell Carcinoma"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/emm2017205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/emm2017205","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/emm.2017.205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/emm2017205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:21:19Z","timestamp":1684430479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/emm2017205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["BFemm2017205"],"URL":"https:\/\/doi.org\/10.1038\/emm.2017.205","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"19 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}